Kraj: Irlandia
Język: angielski
Źródło: HPRA (Health Products Regulatory Authority)
Intervet Ireland Limited
QV07AB
Solvent for Parenteral Use
Immunological - Diluent
Porcine
2008-10-24
IRISH MEDICINES BOARD ACT 1995 EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007 (S.I. NO. 786 OF 2007) VPA: 10996/208/001 Case No: 7005744 The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby grants to: INTERVET IRELAND LIMITED MAGNA DRIVE, MAGNA BUSINESS PARK, DUBLIN 24, IRELAND an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the Veterinary Medicinal Product: DILUVAC FORTE The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may be specified in the said Schedule. The authorisation,unless revoked, shall continue in force from 30/04/2009 until 23/10/2013. Signed on behalf of the Irish Medicines Board ________________ A person authorised in that behalf by the said Board. (NOTE: This authorisation replaces any previous authorisation in respect of this product which is now null and void.) IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 01/05/2009_ _CRN 7005744_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Diluvac Forte 2 QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE(S): Does not contain active ingredients ADJUVANT(S): dl- -tocopheryl acetate For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solvent for parenteral use. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For reconstitution of lyophilised vaccines for which Diluvac Forte is specified to be used as the solvent. 4.3 CONTRAI Przeczytaj cały dokument